Search research articles
Contact Us
Filters
Showing results (161-170 of 311) with videos related to
Page
of 32
Sort By:
Arthritis Care & Research
|
January 26, 2012
Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort
Jean-Frédéric Boyer, Vanina Bongard, Alain Cantagrel, et al.
Arthritis and Rheumatism
|
August 29, 2013
Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome
Gabriel J Tobón, Alain Saraux, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases
|
April 17, 2012
Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry)
Baptiste Glace, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Annals of the Rheumatic Diseases
|
May 23, 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester, Jacques-Eric Gottenberg, Roberto Caporali, et al.
RMD Open
|
January 22, 2025
Impact of Sjögren's disease on quality of sexual life using the Qualisex score
Alexandra Kachaner, Raphaele Seror, Véronique Le Guern, et al.
Joint Bone Spine
|
June 30, 2009
Abatacept therapy and safety management
Thao Pham, Pascal Claudepierre, Arnaud Constantin, et al.
RMD Open
|
April 26, 2016
Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
Guillermo Carvajal Alegria, Dewi Guellec, Xavier Mariette, et al.
Journal of Clinical Medicine
|
September 29, 2017
History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs
Emmanuel Andrès, Rachel Mourot-Cottet, Frédéric Maloisel, et al.
Lancet (London, England)
|
November 24, 2025
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
Ghaith Noaiseh, Kathy L Sivils, Kim Campbell, et al.
Frontiers in Immunology
|
June 14, 2019
Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome
Armen Sanosyan, Claire Daien, Anaïz Nutz, et al.
Page
of 32
Search research articles
Search
Showing results (161-170 of 311) with videos related to
Sort By:
Page
of 32
Arthritis Care & Research
|
January 26, 2012
Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort
Jean-Frédéric Boyer, Vanina Bongard, Alain Cantagrel, et al.
Arthritis and Rheumatism
|
August 29, 2013
Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome
Gabriel J Tobón, Alain Saraux, Jacques-Eric Gottenberg, et al.
Annals of the Rheumatic Diseases
|
April 17, 2012
Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry)
Baptiste Glace, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Annals of the Rheumatic Diseases
|
May 23, 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester, Jacques-Eric Gottenberg, Roberto Caporali, et al.
RMD Open
|
January 22, 2025
Impact of Sjögren's disease on quality of sexual life using the Qualisex score
Alexandra Kachaner, Raphaele Seror, Véronique Le Guern, et al.
Joint Bone Spine
|
June 30, 2009
Abatacept therapy and safety management
Thao Pham, Pascal Claudepierre, Arnaud Constantin, et al.
RMD Open
|
April 26, 2016
Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
Guillermo Carvajal Alegria, Dewi Guellec, Xavier Mariette, et al.
Journal of Clinical Medicine
|
September 29, 2017
History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs
Emmanuel Andrès, Rachel Mourot-Cottet, Frédéric Maloisel, et al.
Lancet (London, England)
|
November 24, 2025
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
Ghaith Noaiseh, Kathy L Sivils, Kim Campbell, et al.
Frontiers in Immunology
|
June 14, 2019
Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome
Armen Sanosyan, Claire Daien, Anaïz Nutz, et al.
Page
of 32